No Data
Fulcrum Therapeutics Inc (FULC) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
Express News | Fulcrum Therapeutics Inc : Leerink Partners Raises Target Price to $16 From $14
Fulcrum Upgraded by Goldman Sachs Ahead of Phase 3 Data
INFN, VYGR and AMSC Are Among After Hour Movers
Fulcrum Therapeutics Raised to Buy From Neutral by Goldman Sachs
Fulcrum Therapeutics Raised to Buy From Neutral by Goldman Sachs
Express News | Goldman Sachs Upgrades Fulcrum Therapeutics to Buy, Announces $15 Price Target